The most award winning
healthcare information source.
TRUSTED FOR FOUR DECADES.
Clinical Scenario: The tachycardia shown in the Figure was obtained from an older woman who presented with shortness of breath and a recent history of "irregular heart beat" episodes. The top strip shows the onset of one such episode, and the bottom strip shows its resolution. What is the probable mechanism of this patient’s arrhythmia? Is the premature ventricular contraction (PVC) seen in the top strip supportive of this diagnosis? How might you treat this patient’s rhythm disorder?
Interpretation: The underlying rhythm is sinus, as suggested by the two normal beats that initiate the top tracing. P wave morphology changes with the third beat, which most likely arises from an ectopic atrial site (EA). Acceleration of the rhythm follows, with development of a tachycardia that manifests an upright but different (ectopic) appearing P wave (E) compared to the sinus-conducted beats. The rate of the tachycardia is approximately 135/minute, and the occurrence of the PVC does nothing to terminate the episode. Gradual slowing is seen in the bottom strip, with conversion of P wave morphology back to the sinus-initiated (P) focus.
The features described and illustrated in the above tracings are characteristic of an ectopic atrial tachycardia (gradual onset and offset of the rhythm with ectopic P wave morphology). Unlike the overwhelming majority of supraventricular tachycardia (SVT) rhythms in adults which are AV-nodal "dependent," ectopic atrial tachycardia arises from an ectopic atrial site that gradually accelerates and is independent of the AV node for its continuation. As a result, neither PVCs nor vagal maneuvers are likely to terminate the rhythm. Treatment consists of correcting the underlying cause (most likely heart failure, pulmonary disease, electrolyte disturbance, digitalis toxicity); AV nodal blocking drugs (for rate control); and occasionally antiarrhythmic agents (to suppress the ectopic atrial site), though the response to such treatment is highly variable.